arrow_back Back Filing freshness 10-Q FY 2024 SEC EDGAR

download Export Data

P3 Health Partners Inc.

PIII

$11.57 ▲ +0.69 (+6.34%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

P3 Health Partners Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $37.8M

Dividend Yield —

Revenue Growth -2.8% ↘

Op. Margin -18.5% ↗

ROIC -371.9% ↘

FCF / Share $-27.91 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -1.47

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.46B

↓ -2.8% —

Net Income Profit after all expenses

$-147.95M

↓ -8.9% —

Operating Margin Operating profit as % of sales

-18.5%

↑ +13.3% 12th

FCF / Share Free cash flow per share

$-27.91

↓ -3579.2% —

Long-Term Debt Long-term obligations

$228.37M

↑ +154.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-2.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-134%)	18.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+131%)	20.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+158%)	81.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+917%)	17.8% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+123%)	237.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2869%)	—
EPS Growth YoY (%)	-4714.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-54.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	90.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	-135.1% Weak ↓ Weak Declining Year-over-year change in net income	78.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-84.5% Weak ↑ Weak Improving Year-over-year change in net income	-366.1% Weak Weak Year-over-year change in net income	25.2% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	-3579.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	7.5% Fair Fair Year-over-year change in free cash flow	73.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	11.6% Good ↓ Good Declining Compound annual revenue growth over 3 years	37.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	37.1% Excellent Excellent Compound annual revenue growth over 3 years	93.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	24.3% Excellent Excellent Compound annual revenue growth over 5 years	59.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-18.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-224%)	-21.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	-13.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-188%)	-148.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1092%)	-22.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-249%)	-5.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-139%)	-27.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-281%)
Effective Tax Rate (%) (%)	-0.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-10.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-184%)	-9.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-175%)	-4.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-138%)	-25.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-314%)	-25.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-311%)	-6.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-153%)	-28.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-340%)
FCF Margin (%) (%)	-6.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-7.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-6.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.2% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-9.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-20.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-371.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-196.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1558.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-161.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-51.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-41.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-178.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	95.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+535%)	-178.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1293%)	-40.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Debt to Equity (x)	-1.47x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-345%)	1.18x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+97%)	0.76x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+27%)	16.13x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2588%)	—	—	—
Interest Coverage (x)	-19.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.60x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-273.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-46.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-41.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	-70.57x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$203.36M	$51.01M	$72.00M	$76.88M	$78.32M	$18.87M	$-32.59M
Debt / EBITDA (x)	-0.85x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.28x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.65x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.66x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.98x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$446.34	$10.34	$13.35	$25.24	—	—	—
Basic EPS, GAAP (USD)	$-45.26	$-0.94	$-0.61	$-6.50	—	—	—
Free Cash Flow per Share (USD)	$-27.91	$-0.76	$-0.82	$-3.08	—	—	—
Book Value per Share (USD)	$-47.49	$0.52	$1.50	$0.14	—	—	—
Tangible Book Value per Share (USD)	$-198.12	$-3.43	$-5.53	$-17.92	—	—	—
Basic Weighted Avg Shares (shares)	3.27M	145.18M	94.89M	41.58M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Working Capital (USD)	$-412.17M	$-312.27M	$-133.35M	$-140.97M	$1.09M	$264.52K	—
LT Debt (USD)	$228.37M	$89.82M	$108.32M	$94.42M	$80.05M	$55.14M	—
Total Equity (USD)	$-155.23M	$75.94M	$142.13M	$5.85M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$1.46B	$1.50B	$1.27B	$1.05B	$578.60M	$491.06M	$145.48M
Depreciation Expense (USD)	$2.20M	$2.40M	$2.30M	$2.40M	$1.54M	$795.17K	$399.18K
Net Income, GAAP (USD)	$-147.95M	$-135.85M	$-57.77M	$-270.13M	$-146.40M	$-31.41M	$-41.97M
Operating Cash Flow (USD)	$-91.24M	$-110.13M	$-76.03M	$-126.02M	$-51.13M	$-24.60M	$-28.29M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters

P3 Health Partners Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PIII with peers